Forced expiratory volume in one second can predict SYNTAX score in patients with chronic obstructive pulmonary disease

Kardiologia Polska

Volumn 74, Issue 6, 2016, Pages 584-590

  Koseoglu, Cemal ^a   Kurmus, Ozge ^b   Ertem, Ahmet Goktug ^c   Colak, Busra ^c   Kirbas, Ozgur ^d   Bilen, Emine ^c   Durmaz, Tahir ^c   Keles, Telat ^c   Bozkurt, Engin ^c  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MERSIN STATE HOSPITAL   (Turkey)

^c ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Forced expiratory volume in one secon; SYNTAX score

Indexed keywords

AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SYNTAX SCORE; COMPLICATION; CORONARY ARTERY BYPASS GRAFT; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE;

EID: 84977484384     PISSN: 00229032     EISSN: 18974279     Source Type: Journal    
DOI: 10.5603/KP.a2015.0236     Document Type: Article

References (25)

1. Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009; 360: 961-972. doi:10.1056/NEJMoa0804626.
2. Murray CJ, Lopez AD. Global mortality, disability and the contribution of risk factors: Global burden of disease study. Lancet, 1997; 349: 1436-1442. doi:10.1016/S0140-6736(96)07495-8.
3. Halbert RJ, Isonaka S, George D et al. Interpreting COPD prevalence estimates: What is the true burden of the disease? Chest, 2003; 123: 1684-1692. doi:10.1378/chest.123.5.1684.
4. Konecny T, Somers K, Orban M, et al. Interactions between COPD and outcomes after percutaneous coronary intervention. Chest, 2010; 138: 621-627. doi:10.1378/chest.10-0300.
5. Saleh HZ, Mohan K, Shaw M et al. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting. Eur J Cardiothorac Surg, 2012; 42: 108-113. doi:10.1093/ejcts/ezr271.
6. Agarwal SK, Heiss G, Barr RG et al. Airflow obstruction, lung function, and risk of incident heart failure: The Atherosclerosis Risk in Communities (ARIC) study. Eur J Heart Fail, 2012; 14: 414-422. doi:10.1093/eurjhf/hfs016.
7. American Thoracic Society.Standardization of spirometry, 1994 update. Ameri J Respir Crit Care Med 1995; 152: 1107-1136. doi:10.1164/ajrccm.152.3.7663792.
8. Global strategy of diagnosis, management and preventing chronic obstructive disease; 2011. www.goldcopd.org. Date last updated: January 2014.
9. Cazzola M, Bettoncelli G, Sessa E et al. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration, 2010; 80: 112-119. doi:10.1159/000281880.
10. Mullerova H, Aqusti A, Erqou S et al. Cardiovascular comorbidity in COPD: Systematic Literature Review. Chest, 2013; 144: 1163-1178. doi:10.1378/chest.12-2847.
11. Liang BM, Xu ZB, Yi Q et al. Association of chronic obstructive pulmonary disease with coronary artery disease. Chin Med J (Engl), 2013; 126: 3205-3208.
12. Topsakal R, Kalay N, Ozdogru I et al. Effects of chronic obstructive pulmonary disease on coronary atherosclerosis. Heart Vessels, 2009; 24: 164-168. doi:10.1007/s00380-008-1103-4.
13. Schroeder EB, Welch VL, Evans GW et al. Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis, 2005; 180: 367-373. doi:10.1016/j.atherosclerosis.2004.12.012.
14. Ding J, Hsu FC, Harris TB et al. The association of pericardial fat with incident coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr, 2009; 90: 499-504. doi:10.3945/ajcn.2008.27358.
15. Zagaceta J, Zulueta JJ, Bastarrika G et al. Epicardial adipose tissue in patients with chronic obstructive pulmonary disease. PLoS One, 2013; 8: 65593. doi:10.1371/journal.pone.0065593.
16. Sabater-Lieal M, Mälarstig A, Folkersen L et al. Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease. PLoS One, 2014; 9: 104082. doi:10.1371/journal.pone.0104082.
17. Libby P. Inflammation and atherosclerosis. Circulation, 2002; 105: 1135-1143. doi:10.1161/hc0902.104353.
18. Sethi S, Mahler DA, Marcus P et al. Inflammation in COPD: implications for management. Am J Med, 2012; 125: 1162-1170. doi:10.1016/j.amjmed.2012.06.024.
19. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular disease? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation, 2003; 107: 1514-1519. doi:10.1161/01.CIR.0000056767.69054.B3.
20. Engström G, Lind P, Hedblad B et al. Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins. Circulation, 2002; 106: 2555-2560. doi10.1161/01.CIR.0000037220.00065.0D.
21. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation, 2004; 109: III27-III32. doi:10.1161/01.CIR.0000131515.03336.f8.
22. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease.Oxidative stress Study Group. Am J Respir Crit Care Med, 1997; 156: 341-357. doi:10.1164/ajrccm.156.2.9611013.
23. Shen Y, Yang T, Guo S et al. Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPD. Mediators Inflamm, 2013; 2013: 972347. doi:10.1155/2013/972347.
24. Barr RG, Mesia-Vela S, Austin JH, et al. Impaired flow-mediated dilatation is associated with low pulmonary function and emphysema in ex-smokers: The Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med, 2007; 176: 1200-1207. doi:10.1164/rccm.200707-980OC.
25. Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: Epidemiology, significance, and management: pulmonary vascular disease: The global perspective. Chest, 2010; 137: 39-51. doi:10.1378/chest.10-0087.